SAM-e supplement
Selected indexed studies
- SAM-e. (, 2006) [PMID:30000930]
- Gluconeogenic enzyme PCK1 supports S-adenosylmethionine biosynthesis and promotes H3K9me3 modification to suppress hepatocellular carcinoma progression. (J Clin Invest, 2023) [PMID:37166978]
- Folic Acid, Folinic Acid, 5 Methyl TetraHydroFolate Supplementation for Mutations That Affect Epigenesis through the Folate and One-Carbon Cycles. (Biomolecules, 2022) [PMID:35204698]
_Worker-drafted node — pending editorial review._
Connections
SAM-e supplement helps
SAM-e supplement protects against
Sources
- Betaine and aging: A narrative review of findings, possible mechanisms, research perspectives, and practical recommendations. (2025) pubmed
- Evidence for S-adenosyl-L-methionine (SAM-e) for the treatment of major depressive disorder. (2009) pubmed
- S-Adenosylmethionine (SAMe) for Liver Health: A Systematic Review. (2024) pubmed
- SAM-e. (2006) pubmed
- Gluconeogenic enzyme PCK1 supports S-adenosylmethionine biosynthesis and promotes H3K9me3 modification to suppress hepatocellular carcinoma progression. (2023) pubmed
- Folic Acid, Folinic Acid, 5 Methyl TetraHydroFolate Supplementation for Mutations That Affect Epigenesis through the Folate and One-Carbon Cycles. (2022) pubmed
- Neuronutritional Approach to Fibromyalgia Management: A Narrative Review. (2024) pubmed
- Treatment and outcomes of dogs with hepatocutaneous syndrome or hepatocutaneous-associated hepatopathy. (2022) pubmed
- [Other therapeutic strategies]. (2016) pubmed
- S-adenosylmethionine and depression. (2002) pubmed